178 related articles for article (PubMed ID: 10200059)
21. Intron retention and frameshift mutations result in severe pyruvate carboxylase deficiency in two male siblings.
Carbone MA; Applegarth DA; Robinson BH
Hum Mutat; 2002 Jul; 20(1):48-56. PubMed ID: 12112657
[TBL] [Abstract][Full Text] [Related]
22. The gene encoding alpha-galactosidase A and gene rearrangements causing Fabry disease.
Kornreich R; Bishop DF; Desnick RJ
Trans Assoc Am Physicians; 1989; 102():30-43. PubMed ID: 2561643
[No Abstract] [Full Text] [Related]
23. Fabry disease: 20 novel GLA mutations in 35 families.
Blaydon D; Hill J; Winchester B
Hum Mutat; 2001 Nov; 18(5):459. PubMed ID: 11668641
[TBL] [Abstract][Full Text] [Related]
24. A mutant mRNA expression in an endomyocardial biopsy sample obtained from a patient with a cardiac variant of Fabry disease caused by a novel acceptor splice site mutation in the invariant AG of intron 5 of the α-galactosidase A gene.
Watanabe T; Hanawa H; Suzuki T; Jiao S; Yoshida K; Ogura M; Ohno Y; Hayashi Y; Ito M; Kashimura T; Obata H; Sato A; Ozawa T; Kodama M; Sakuraba H; Minamino T
Intern Med; 2013; 52(7):777-80. PubMed ID: 23545674
[TBL] [Abstract][Full Text] [Related]
25. Nucleotide changes around the splicing acceptor of intron 24 in the factor VIII gene and its impact on splicing.
Gau JP; Chen CC; Hsu HC; Ho CH; Chau WK; You JY; Yu YB
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):53-6. PubMed ID: 16607080
[TBL] [Abstract][Full Text] [Related]
26. Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease.
Schäfer E; Baron K; Widmer U; Deegan P; Neumann HP; Sunder-Plassmann G; Johansson JO; Whybra C; Ries M; Pastores GM; Mehta A; Beck M; Gal A
Hum Mutat; 2005 Apr; 25(4):412. PubMed ID: 15776423
[TBL] [Abstract][Full Text] [Related]
27. Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease.
Chien YH; Hwu WL
Hum Genet; 2009 Apr; 125(3):336. PubMed ID: 19309781
[No Abstract] [Full Text] [Related]
28. [Molecular genetics of inherited metabolic diseases--its application to the investigation of pathogenesis and the diagnosis of Fabry disease].
Sakuraba H
Rinsho Byori; 1994 Jun; 42(6):628-35. PubMed ID: 7914243
[TBL] [Abstract][Full Text] [Related]
29. Fabry disease in a female patient due to a de novo point mutation at position 691 of exon 5.
Brokalaki EI; Hentschke M; Grabbe S; Jansen T
Eur J Med Res; 2006 Jul; 11(7):306-8. PubMed ID: 16899426
[TBL] [Abstract][Full Text] [Related]
30. Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma.
Froissart R; Guffon N; Vanier MT; Desnick RJ; Maire I
Mol Genet Metab; 2003 Nov; 80(3):307-14. PubMed ID: 14680977
[TBL] [Abstract][Full Text] [Related]
31. Fabry disease: identification of 50 novel alpha-galactosidase A mutations causing the classic phenotype and three-dimensional structural analysis of 29 missense mutations.
Shabbeer J; Yasuda M; Benson SD; Desnick RJ
Hum Genomics; 2006 Mar; 2(5):297-309. PubMed ID: 16595074
[TBL] [Abstract][Full Text] [Related]
32. Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease.
Chien YH
Hum Genet; 2009 Apr; 125(3):336. PubMed ID: 19309800
[No Abstract] [Full Text] [Related]
33. Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease.
Lin HY; Chong KW; Hsu JH; Yu HC; Huang CH; Niu DM
Hum Genet; 2010 Jan; 127(1):124. PubMed ID: 20108438
[No Abstract] [Full Text] [Related]
34. Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease.
Niu DM; Lin HY; Chong KW; Hsu JH; Yu HC; Huang CH
Hum Genet; 2010 Jan; 127(1):122. PubMed ID: 20108436
[No Abstract] [Full Text] [Related]
35. Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease.
Lin HY; Niu DM; Chong KW; Hsu JH; Yu HC; Huang CH
Hum Genet; 2010 Jan; 127(1):122-3. PubMed ID: 20108401
[No Abstract] [Full Text] [Related]
36. Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young.
Bulman MP; Harries LW; Hansen T; Shepherd M; Kelly WF; Hattersley AT; Ellard S
Diabetologia; 2002 Oct; 45(10):1463-7. PubMed ID: 12378390
[TBL] [Abstract][Full Text] [Related]
37. Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele.
Yasuda M; Shabbeer J; Benson SD; Maire I; Burnett RM; Desnick RJ
Hum Mutat; 2003 Dec; 22(6):486-92. PubMed ID: 14635108
[TBL] [Abstract][Full Text] [Related]
38. Alternative splicing in the alpha-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype.
Ishii S; Nakao S; Minamikawa-Tachino R; Desnick RJ; Fan JQ
Am J Hum Genet; 2002 Apr; 70(4):994-1002. PubMed ID: 11828341
[TBL] [Abstract][Full Text] [Related]
39. Mutation analysis of the ornithine transcarbamylase (OTC) gene in five Japanese OTC deficiency patients revealed two known and three novel mutations including a deep intronic mutation.
Ogino W; Takeshima Y; Nishiyama A; Okizuka Y; Yagi M; Tsuneishi S; Saiki K; Kugo M; Matsuo M
Kobe J Med Sci; 2007; 53(5):229-40. PubMed ID: 18204299
[TBL] [Abstract][Full Text] [Related]
40. Fabry disease: detection of 13-bp deletion in alpha-galactosidase A gene and its application to gene diagnosis of heterozygotes.
Ishii S; Sakuraba H; Shimmoto M; Minamikawa-Tachino R; Suzuki T; Suzuki Y
Ann Neurol; 1991 May; 29(5):560-4. PubMed ID: 1650161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
